INS and Insulin resistance: At the same time, LXR inhibits the activation of insulin resistance-related c-Jun amino-terminal kinase (JNK) signaling pathway, improves insulin signal transduction, restores insulin sensitivity of cells, and promotes glucose uptake and utilization [22].